Pharmacy Benefit Management Market Size, Share, and Trends 2024 to 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Pharmacy Benefit Management Market 

5.1. COVID-19 Landscape: Pharmacy Benefit Management Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Pharmacy Benefit Management Market, By Service

8.1. Pharmacy Benefit Management Market, by Service, 2024-2033

8.1.1 Specialty Pharmacy Services

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. Benefit Plan Design & Administration

8.1.2.1. Market Revenue and Forecast (2021-2033)

8.1.3. Formulary Management

8.1.3.1. Market Revenue and Forecast (2021-2033)

8.1.4. Pharmacy Claims Processing

8.1.4.1. Market Revenue and Forecast (2021-2033)

8.1.5. Others

8.1.5.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global Pharmacy Benefit Management Market, By Service Provider

9.1. Pharmacy Benefit Management Market, by Service Provider, 2024-2033

9.1.1. Retail Pharmacies

9.1.1.1. Market Revenue and Forecast (2021-2033)

9.1.2. Insurance Companies

9.1.2.1. Market Revenue and Forecast (2021-2033)

9.1.3. Standalone Pharmacy Benefit Management Providers

9.1.3.1. Market Revenue and Forecast (2021-2033)

Chapter 10. Global Pharmacy Benefit Management Market, By Business Model 

10.1. Pharmacy Benefit Management Market, by Business Model, 2024-2033

10.1.1. Government Health Programs

10.1.1.1. Market Revenue and Forecast (2021-2033)

10.1.2. Employer-sponsored Programs

10.1.2.1. Market Revenue and Forecast (2021-2033)

10.1.3. Health Insurance Management

10.1.3.1. Market Revenue and Forecast (2021-2033)

Chapter 11. Global Pharmacy Benefit Management Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Service (2021-2033)

11.1.2. Market Revenue and Forecast, by Service Provider (2021-2033)

11.1.3. Market Revenue and Forecast, by Business Model (2021-2033)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Service (2021-2033)

11.1.4.2. Market Revenue and Forecast, by Service Provider (2021-2033)

11.1.4.3. Market Revenue and Forecast, by Business Model (2021-2033)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Service (2021-2033)

11.1.5.2. Market Revenue and Forecast, by Service Provider (2021-2033)

11.1.5.3. Market Revenue and Forecast, by Business Model (2021-2033)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Service (2021-2033)

11.2.2. Market Revenue and Forecast, by Service Provider (2021-2033)

11.2.3. Market Revenue and Forecast, by Business Model (2021-2033)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Service (2021-2033)

11.2.4.2. Market Revenue and Forecast, by Service Provider (2021-2033)

11.2.4.3. Market Revenue and Forecast, by Business Model (2021-2033)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Service (2021-2033)

11.2.5.2. Market Revenue and Forecast, by Service Provider (2021-2033)

11.2.5.3. Market Revenue and Forecast, by Business Model (2021-2033)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Service (2021-2033)

11.2.6.2. Market Revenue and Forecast, by Service Provider (2021-2033)

11.2.6.3. Market Revenue and Forecast, by Business Model (2021-2033)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Service (2021-2033)

11.2.7.2. Market Revenue and Forecast, by Service Provider (2021-2033)

11.2.7.3. Market Revenue and Forecast, by Business Model (2021-2033)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Service (2021-2033)

11.3.2. Market Revenue and Forecast, by Service Provider (2021-2033)

11.3.3. Market Revenue and Forecast, by Business Model (2021-2033)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Service (2021-2033)

11.3.4.2. Market Revenue and Forecast, by Service Provider (2021-2033)

11.3.4.3. Market Revenue and Forecast, by Business Model (2021-2033)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Service (2021-2033)

11.3.5.2. Market Revenue and Forecast, by Service Provider (2021-2033)

11.3.5.3. Market Revenue and Forecast, by Business Model (2021-2033)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Service (2021-2033)

11.3.6.2. Market Revenue and Forecast, by Service Provider (2021-2033)

11.3.6.3. Market Revenue and Forecast, by Business Model (2021-2033)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Service (2021-2033)

11.3.7.2. Market Revenue and Forecast, by Service Provider (2021-2033)

11.3.7.3. Market Revenue and Forecast, by Business Model (2021-2033)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Service (2021-2033)

11.4.2. Market Revenue and Forecast, by Service Provider (2021-2033)

11.4.3. Market Revenue and Forecast, by Business Model (2021-2033)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Service (2021-2033)

11.4.4.2. Market Revenue and Forecast, by Service Provider (2021-2033)

11.4.4.3. Market Revenue and Forecast, by Business Model (2021-2033)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Service (2021-2033)

11.4.5.2. Market Revenue and Forecast, by Service Provider (2021-2033)

11.4.5.3. Market Revenue and Forecast, by Business Model (2021-2033)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Service (2021-2033)

11.4.6.2. Market Revenue and Forecast, by Service Provider (2021-2033)

11.4.6.3. Market Revenue and Forecast, by Business Model (2021-2033)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Service (2021-2033)

11.4.7.2. Market Revenue and Forecast, by Service Provider (2021-2033)

11.4.7.3. Market Revenue and Forecast, by Business Model (2021-2033)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Service (2021-2033)

11.5.2. Market Revenue and Forecast, by Service Provider (2021-2033)

11.5.3. Market Revenue and Forecast, by Business Model (2021-2033)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Service (2021-2033)

11.5.4.2. Market Revenue and Forecast, by Service Provider (2021-2033)

11.5.4.3. Market Revenue and Forecast, by Business Model (2021-2033)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Service (2021-2033)

11.5.5.2. Market Revenue and Forecast, by Service Provider (2021-2033)

11.5.5.3. Market Revenue and Forecast, by Business Model (2021-2033)

Chapter 12. Company Profiles

12.1. CVS Health

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. SS&C Technologies, Inc.

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Anthem Inc.

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Medimpact

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Express Scripts Holding Company

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Benecard Services, LLC

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. CaptureRx Inc.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Change Healthcare

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. OptumRx, Inc.

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Cigna

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms